Literature DB >> 15761425

Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors.

Tracy J Lovatt1, John T Lear, Jean Bastrilles, Christina Wong, Christopher E M Griffiths, Venura Samarasinghe, Jamie Roebuck, Sudarshan Ramachandran, Andrew G Smith, Peter W Jones, Anthony A Fryer, Richard C Strange.   

Abstract

BACKGROUND: Patients with basal cell carcinoma (BCC) frequently develop further tumors during follow-up.
OBJECTIVE: We sought to elucidate the relative effects of pattern of ultraviolet radiation exposure, and site and histologic type of the first tumor, on the rate of increase in BCC numbers.
METHODS: We used negative binomial regression analysis to study the association of selected variables on the rate of increase in BCC numbers in 266 Caucasian patients who first presented with a tumor on the head/neck or trunk with nodular or superficial histology.
RESULTS: Patients with an initial truncal BCC with superficial histology demonstrated significantly faster increases in BCC numbers than did patients with other site and histology combinations.
CONCLUSIONS: These data indicate that site and histology define subsets of patients with BCC.

Entities:  

Mesh:

Year:  2005        PMID: 15761425     DOI: 10.1016/j.jaad.2004.08.060

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  24 in total

1.  [Basal cell carcinoma of the periocular region].

Authors:  F Geszti; D Hargitai; O Lukáts; H Győrffy; J Tóth
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

2.  Electrochemotherapy: a good idea in recurrent basal cell carcinoma treatment.

Authors:  Roberta Ruggeri; Andrea Maurichi; Maria Carla Tinti; Pierfrancesco Cadenelli; Roberto Patuzzo; Gianfrancesco Gallino; Mario Santinami
Journal:  Melanoma Manag       Date:  2015-02-25

3.  Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation.

Authors:  Lawrence F Kuklinski; Shufeng Li; Margaret R Karagas; Wen-Kai Weng; Bernice Y Kwong
Journal:  J Am Acad Dermatol       Date:  2017-08-02       Impact factor: 11.527

4.  Polymorphisms in the nuclear excision repair gene ERCC2/XPD and susceptibility to cutaneous basal cell carcinoma.

Authors:  Ying Sun; Zhihong Liu; Ying Liu; Xia Li
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  Predicting the Risk of a Second Basal Cell Carcinoma.

Authors:  Joris A C Verkouteren; Hilde Smedinga; Ewout W Steyerberg; Albert Hofman; Tamar Nijsten
Journal:  J Invest Dermatol       Date:  2015-03-03       Impact factor: 8.551

6.  CASE REPORT Superficial Spreading Basal Cell Carcinoma of the Face: A Surgical Challenge.

Authors:  Yuri T Jadotte; Navér A Sarkissian; Helchem Kadire; W Clark Lambert
Journal:  Eplasty       Date:  2010-06-21

7.  Nonmelanoma skin cancer and risk for subsequent malignancy.

Authors:  Jiping Chen; Ingo Ruczinski; Timothy J Jorgensen; Gayane Yenokyan; Yin Yao; Rhoda Alani; Nanette J Liégeois; Sandra C Hoffman; Judith Hoffman-Bolton; Paul T Strickland; Kathy J Helzlsouer; Anthony J Alberg
Journal:  J Natl Cancer Inst       Date:  2008-08-26       Impact factor: 13.506

8.  GLI1 genotypes do not predict basal cell carcinoma risk: a case control study.

Authors:  Andrea Watson; Paul Kent; Murad Alam; Amy S Paller; David M Umbach; Joon Won Yoon; Philip M Iannaccone; David O Walterhouse
Journal:  Mol Cancer       Date:  2009-11-30       Impact factor: 27.401

9.  ARLTS1 polymorphisms and basal cell carcinoma of the skin.

Authors:  Xuchen Li; Andreas Gast; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Kari Hemminki; Rajiv Kumar
Journal:  Hered Cancer Clin Pract       Date:  2007-03-15       Impact factor: 2.857

10.  Keratinocytes from Gorlin Syndrome-induced pluripotent stem cells are resistant against UV radiation.

Authors:  Nana Morita; Shoko Onodera; Yuriko Nakamura; Takashi Nakamura; Shin-Ichi Takahashi; Takeshi Nomura; Toshifumi Azuma
Journal:  Med Mol Morphol       Date:  2020-08-20       Impact factor: 2.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.